King Pharmaceuticals faces Item Development AB in patent interference involving myocardial dysfunction
Clients King Pharmaceuticals Research & Development, Inc.
Jones Day provided representation to King Pharmaceuticals, Inc. in a patent interference against Item Development AB before the U.S. Patent and Trademark Office involving methods for detecting the presence and assessing the severity of myocardial dysfunction.
King Pharmaceuticals Research & Development, Inc. v. Item Development AB, Interference No. 105,620